David R. Rahn & Associates Inc. Edwards Lifesciences Corp Transaction History
David R. Rahn & Associates Inc.
- $294 Million
- Q4 2024
A detailed history of David R. Rahn & Associates Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, David R. Rahn & Associates Inc. holds 4,479 shares of EW stock, worth $320,382. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,479
Previous 4,714
4.99%
Holding current value
$320,382
Previous $311,000
6.43%
% of portfolio
0.11%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding EW
# of Institutions
1,383Shares Held
453MCall Options Held
6.71MPut Options Held
3.17M-
Vanguard Group Inc Valley Forge, PA69.1MShares$4.95 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.65 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.85 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY14.9MShares$1.06 Billion0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA13.6MShares$976 Million0.08% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $44.2B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...